INTERNATIONAL FLAVORS & FRAGRANCES INC
IFFAPI behind this page
IFF FY 2025 request
Playground key active
/api/financials?ticker=IFF&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 3,278 | 3,365 | -2.6% |
| Health & Biosciences · Operating Segments | 2,283 | 2,203 | +3.6% |
| Pharma Solutions · Operating Segments | 369 | 1,049 | -64.8% |
| Scent · Operating Segments | 2,479 | 2,439 | +1.6% |
| Taste · Operating Segments | 2,481 | 2,428 | +2.2% |
Show Geography breakouts |
|||
| Asia | 2,546 | 2,731 | -6.8% |
| EMEA | 3,727 | 3,840 | -2.9% |
| Latin America | 1,422 | 1,473 | -3.5% |
| North America | 3,195 | 3,440 | -7.1% |
Show — breakouts |
|||
| Revenue | 10,890 | 11,484 | -5.2% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 10,890 | 11,484 | -5.2% |
Show Geographic Distribution breakouts |
|||
| Non Us | 7,815 | 8,265 | -5.4% |
| US | 3,075 | 3,219 | -4.5% |
| Cost of Revenue (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 2,531 | 2,626 | -3.6% |
| Health & Biosciences · Operating Segments | 1,246 | 1,183 | +5.3% |
| Pharma Solutions · Operating Segments | 248 | 719 | -65.5% |
| Scent · Operating Segments | 1,424 | 1,361 | +4.6% |
| Taste · Operating Segments | 1,500 | 1,470 | +2.0% |
Show — breakouts |
|||
| Cost of Revenue | 6,952 | 7,360 | -5.5% |
| Gross Profit (FY) | — | — | — |
Show — breakouts |
|||
| Gross Profit | 3,938 | 4,124 | -4.5% |
| Research & Development (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 54 | 71 | -23.9% |
| Health & Biosciences · Operating Segments | 219 | 190 | +15.3% |
| Pharma Solutions · Operating Segments | 8 | 25 | -68.0% |
| Scent · Operating Segments | 241 | 225 | +7.1% |
| Taste · Operating Segments | 172 | 160 | +7.5% |
Show — breakouts |
|||
| Research & Development | 694 | 671 | +3.4% |
| Selling, General & Administrative (FY) | — | — | — |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 400 | 391 | +2.3% |
| Health & Biosciences · Operating Segments | 348 | 368 | -5.4% |
| Pharma Solutions · Operating Segments | 42 | 115 | -63.5% |
| Scent · Operating Segments | 366 | 376 | -2.7% |
| Taste · Operating Segments | 396 | 403 | -1.7% |
Show — breakouts |
|||
| Selling, General & Administrative | 1,834 | 1,995 | -8.1% |
| Operating Income (FY) | — | — | — |
Show — breakouts |
|||
| Operating Income | -382 | 766 | -149.9% |
| Interest Expense (FY) | — | — | — |
Show — breakouts |
|||
| Interest Expense | 229 | 305 | -24.9% |
| Interest Income (FY) | — | — | — |
Show — breakouts |
|||
| Interest Income | 19 | 15 | +26.7% |
| Other Non-Operating Income (Expense) (FY) | — | — | — |
Show — breakouts |
|||
| Other Non-Operating Income (Expense) | 65 | 182 | -64.3% |
| Income Before Taxes (FY) | — | — | — |
Show — breakouts |
|||
| Income Before Taxes | -412 | 308 | -233.8% |
| Income Tax Expense (Benefit) (FY) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest · Reclassification Out Of Accumulated Other Comprehensive Income | -1 | -47 | +97.9% |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | -53 | 41 | -229.3% |
Show Income Tax Expense, Component [Axis] breakouts |
|||
| Global Intangible Low-Taxed Income (GILTI) | 215 | — | — |
| Tax Credit, Foreign | -178 | — | — |
| Net Income (FY) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Including Portion Attributable To Noncontrolling Interest · Reclassification Out Of Accumulated Other Comprehensive Income | 46 | -93 | +149.5% |
Show — breakouts |
|||
| Net Income | -359 | 267 | -234.5% |
| Comprehensive Income (FY) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 736 | -368 | +300.0% |
| EPS (Basic) (FY) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | -1.41 | 1.04 | -235.6% |
| EPS (Diluted) (FY) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | -1.41 | 1.04 | -235.6% |
| Wtd Avg Shares (Basic) (FY) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Basic) | 256 | 256 | 0.0% |
| Wtd Avg Shares (Diluted) (FY) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | 256 | 256 | 0.0% |
| Net Income Loss Available To Common Stockholders Basic (FY) | — | — | — |
Show — breakouts |
|||
| Net Income Loss Available To Common Stockholders Basic | -361 | 263 | -237.3% |
| Net Income Loss Attributable To Noncontrolling Interest (FY) | — | — | — |
Show — breakouts |
|||
| Net Income Loss Attributable To Noncontrolling Interest | 2 | 4 | -50.0% |
| Foreign Currency Transaction Gain Loss Before Tax (FY) | — | — | — |
Show — breakouts |
|||
| Foreign Currency Transaction Gain Loss Before Tax | -92 | -91 | -1.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 590 | 469 | +25.8% |
| Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Inventory | 2,245 | 2,133 | +5.3% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 5,594 | 7,968 | -29.8% |
| Non-Current Assets | |||
| Property, Plant & Equipment (Q) | — | — | — |
Show Geography breakouts |
|||
| Non Us | 2,409 | 2,129 | +13.2% |
| US | 1,620 | 1,610 | +0.6% |
Show — breakouts |
|||
| Property, Plant & Equipment | 4,029 | 3,739 | +7.8% |
| Operating Lease Right-of-Use Assets (Q) | — | — | — |
Show — breakouts |
|||
| Operating Lease Right-of-Use Assets | 579 | 589 | -1.7% |
Show Disposal Group Classification breakouts |
|||
| Disposal Group Heldforsale Not Discontinued Operations · SCL Disposal Group | 7 | — | — |
| Goodwill (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Health & Biosciences | 4,465 | 4,295 | +4.0% |
| Scent | 1,508 | 1,465 | +2.9% |
| Taste | 2,296 | — | — |
Show — breakouts |
|||
| Goodwill | 8,269 | 9,075 | -8.9% |
| Intangible Assets (Q) | — | — | — |
Show — breakouts |
|||
| Intangible Assets | 6,043 | 6,445 | -6.2% |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 1,025 | 907 | +13.0% |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 25,539 | 28,723 | -11.1% |
| Current Liabilities | |||
| Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable | 1,287 | 1,283 | +0.3% |
| Commercial Paper (Q) | — | — | — |
Show — breakouts |
|||
| Commercial Paper | 314 | — | — |
| Current Portion of Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Current Portion of Long-Term Debt | -1,254 | -1,413 | +11.3% |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 3,933 | 4,352 | -9.6% |
| Debt Current (Q) | — | — | — |
Show — breakouts |
|||
| Debt Current | 1,254 | 1,413 | -11.3% |
| Non-Current Liabilities | |||
| Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Long-Term Debt | 4,740 | 7,564 | -37.3% |
| Long-Term Debt (Q) | — | — | — |
Show — breakouts |
|||
| Long-Term Debt | 5,637 | — | — |
| Operating Lease Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Operating Lease Liabilities | 533 | 550 | -3.1% |
| Deferred Tax Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Liabilities | 1,379 | 1,594 | -13.5% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 582 | 627 | -7.2% |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock | 35 | 35 | 0.0% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | -3,417 | -2,647 | -29.1% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -1,430 | -2,527 | +43.4% |
| Total Stockholders' Equity (Q) | — | — | — |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -153 | -99 | -54.5% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -4 | -2 | -100.0% |
| Accumulated Other Comprehensive Income | -1,430 | -2,527 | +43.4% |
| Accumulated Translation Adjustment | -1,273 | -2,426 | +47.5% |
Show — breakouts |
|||
| Total Stockholders' Equity | 14,154 | 13,834 | +2.3% |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 25,539 | 28,723 | -11.1% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization (FY) | — | — | — |
Show — breakouts |
|||
| Depreciation & Amortization | 962 | 1,015 | -5.2% |
| Stock-Based Compensation (FY) | — | — | — |
Show — breakouts |
|||
| Stock-Based Compensation | 88 | 77 | +14.3% |
| Deferred Income Taxes (FY) | — | — | — |
Show — breakouts |
|||
| Deferred Income Taxes | -270 | -323 | +16.4% |
| Change in Accounts Receivable (FY) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Receivable | -68 | -217 | +68.7% |
| Change in Inventory (FY) | — | — | — |
Show — breakouts |
|||
| Change in Inventory | -41 | -34 | -20.6% |
| Change in Accounts Payable (FY) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Payable | -57 | 40 | -242.5% |
| Net Cash from Operations (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | 850 | 1,070 | -20.6% |
| Investing Activities | |||
| Capital Expenditures (FY) | — | — | — |
Show — breakouts |
|||
| Capital Expenditures | -594 | -463 | -28.3% |
| Net Cash from Investing (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | 2,269 | 326 | +596.0% |
| Financing Activities | |||
| Share Repurchases (FY) | — | — | — |
Show — breakouts |
|||
| Share Repurchases | -38 | — | — |
| Tax Withholding for Share Compensation (FY) | — | — | — |
Show — breakouts |
|||
| Tax Withholding for Share Compensation | -24 | -16 | -50.0% |
| Debt Repayments (FY) | — | — | — |
Show Debt Instrument breakouts |
|||
| Senior Notes, Euro Notes, 2024 · Loans Payable | 500 | — | — |
| Net Cash from Financing (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | -3,091 | -1,606 | -92.5% |
| Supplemental | |||
| Income Taxes Paid (FY) | — | — | — |
Show — breakouts |
|||
| Income Taxes Paid | 329 | — | — |
| Interest Paid (FY) | — | — | — |
Show — breakouts |
|||
| Interest Paid | 229 | 308 | -25.6% |
| Unpaid Capital Expenditures (FY) | — | — | — |
Show — breakouts |
|||
| Unpaid Capital Expenditures | 176 | 158 | +11.4% |
| Other Cash Flow | |||
| Net Change in Cash (FY) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | 119 | -264 | +145.1% |
Values in millions USD. Source: SEC EDGAR 10-K filing.